Logo

American Heart Association

  1
  0


Final ID: TP22

Risk of Intracerebral Hemorrhage from Adjunct Intra-arterial Thrombolysis in Acute Ischemic Stroke Patients Undergoing Thrombectomy

Abstract Body: Background and Purpose: Intra-arterial thrombolysis as an adjunct to mechanical thrombectomy is increasingly being considered to enhance reperfusion in acute ischemic stroke patients. Intra-arterial thrombolysis may increase the risk of post-thrombectomy intracerebral hemorrhage (ICH) in certain patient subgroups.
Methods: We analyzed acute ischemic stroke patients treated with mechanical thrombectomy in a multicenter registry. The occurrence of any (asymptomatic and symptomatic) post-thrombectomy ICH was ascertained using standard definition requiring serial neurological examinations and computed tomographic scans. We determined the risk of ICH in subgroups defined by clinical characteristics, and use of intravenous (IV) thrombolysis.
Results: A total of 146 (7.5%) patients received intra-thrombolysis among 1953 acute ischemic stroke patients who underwent mechanical thrombectomy. The proportion of patients who developed any ICH was 26 (17.8%) and 510 (28.2%) among patients who were and were not treated with intra-arterial thrombolysis (p=0.006). Among patients who received IV thrombolysis (n=1042), the proportion of patients who developed ICH was 9 (16.7%) and 294 (30.7%) among patients who were and were not treated with intra-arterial thrombolysis (p=0.028). The risk was not different in strata defined by age, gender, location of occlusion, pre-procedure National Institutes of Health Stroke Scale score, time interval between symptom onset and thrombectomy, Alberta Stroke Program Early CT score, systolic blood pressure, and serum glucose concentrations.
Conclusions: In patients undergoing mechanical thrombectomy, the risk of any ICH and sICH was not increased with intra-arterial thrombolysis, including in those who had already received IV thrombolytics.
  • Qureshi, Adnan  ( University of Missouri , Columbia , Missouri , United States )
  • Veznedaroglu, Erol  ( Global Neuroscience Institute , Philadelphia , Pennsylvania , United States )
  • Budzik, Ronald  ( Riverside Methodist Hospital , Columbus , Ohio , United States )
  • Gupta, Rishi  ( WELLSTAR HEALTH SYSTEM , Marietta , Georgia , United States )
  • Nogueira, Raul  ( University of Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Krajina, Antonin  ( Charles University , Hradec Králové , Czechia )
  • Bartolini, Bruno  ( Lausanne University Hospital , Lausanne , Switzerland )
  • English, Joey  ( Sutter California Pacific Medical Center , San Francisco , California , United States )
  • Baxter, Blaise  ( Lehigh Valley Health Network Allentown , Lehigh County , Pennsylvania , United States )
  • Liebeskind, David  ( UCLA , Los Angeles , California , United States )
  • Huang, Yilun  ( University of Missouri , Columbia , Missouri , United States )
  • Bhatti, Ibrahim  ( University of Missouri , Columbia , Missouri , United States )
  • Gomez, Camilo  ( University of Missouri , Columbia , Missouri , United States )
  • Hanley, Daniel  ( JOHNS HOPKINS UNIVERSITY , Baltimore , Maryland , United States )
  • Ford, Daniel  ( John Hopkins University , Baltimore , Maryland , United States )
  • Hassan, Ameer  ( UTRGV - VALLEY BAPTIST MEDICAL CENT , Harlingen , Texas , United States )
  • Nguyen, Thanh  ( Boston Medical Center , Boston , Massachusetts , United States )
  • Spiotta, Alejandro  ( MUSC , Charleston , South Carolina , United States )
  • Author Disclosures:
    Adnan Qureshi: DO have relevant financial relationships ; Ownership Interest:Qureshi Medical LLC:Active (exists now) ; Ownership Interest:QuReVasc LLC:Active (exists now) ; Ownership Interest:DyQure LLC:Active (exists now) | Erol Veznedaroglu: No Answer | Ronald Budzik: No Answer | Rishi Gupta: No Answer | Raul Nogueira: DO have relevant financial relationships ; Consultant:Stryker:Active (exists now) ; Consultant:Phenox:Active (exists now) ; Individual Stocks/Stock Options:Vesalio:Active (exists now) ; Individual Stocks/Stock Options:Rapid Pulse:Active (exists now) ; Individual Stocks/Stock Options:Euphrates :Active (exists now) ; Individual Stocks/Stock Options:Brainomix:Active (exists now) ; Individual Stocks/Stock Options:Viz.AI:Active (exists now) ; Consultant:Perfuze:Active (exists now) ; Consultant:Route 92:Active (exists now) ; Consultant:Imperative Care:Active (exists now) ; Consultant:Microvention:Active (exists now) ; Consultant:Medtronic :Active (exists now) ; Consultant:Cerenovus:Active (exists now) | Antonin Krajina: No Answer | Bruno Bartolini: No Answer | Joey English: DO have relevant financial relationships ; Consultant:Route 92 Medical:Active (exists now) ; Consultant:Stryker Neurovascular:Active (exists now) ; Other (please indicate in the box next to the company name):Route 92 Medical Chief Medical Officer:Active (exists now) ; Royalties/Patent Beneficiary:Route 92 Medical:Active (exists now) ; Ownership Interest:Route 92 Medical:Active (exists now) | Blaise Baxter: No Answer | David Liebeskind: DO NOT have relevant financial relationships | Yilun Huang: No Answer | Ibrahim Bhatti: DO NOT have relevant financial relationships | Camilo Gomez: No Answer | Daniel Hanley: DO have relevant financial relationships ; Consultant:HiCatlyst:Active (exists now) ; Research Funding (PI or named investigator):U.S. Department of Defense W911QY2090012:Active (exists now) ; Research Funding (PI or named investigator):NIH/NCATS U24TR001609:Past (completed) ; Research Funding (PI or named investigator):NIH/NCATS U24TR004440:Active (exists now) ; Ownership Interest:EpiWatch:Active (exists now) | Daniel Ford: DO NOT have relevant financial relationships | Ameer Hassan: DO have relevant financial relationships ; Consultant:Medtronic, Microvention, Stryker, Penumbra, Cerenovus, Genentech, GE Healthcare, Scientia, Balt, Viz.ai , Insera therapeutics, Proximie, NeuroVasc, NovaSignal, Vesalio, Rapid Medical, Imperative Care, Galaxy Therapeutics, Route 92, Perfuze, CorTech, Shockwave and Xcath:Active (exists now) | Thanh Nguyen: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):American Stroke Association:Active (exists now) ; Advisor:Aruna Bio:Past (completed) ; Advisor:Brainomix:Active (exists now) | Alejandro Spiotta: DO have relevant financial relationships ; Consultant:Penumbra:Past (completed) ; Research Funding (PI or named investigator):RapidAI:Past (completed) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Stryker:Active (exists now) ; Research Funding (PI or named investigator):Microvention:Active (exists now) ; Research Funding (PI or named investigator):Penumbra:Active (exists now) ; Consultant:Terumo:Active (exists now) ; Consultant:RapidAI:Past (completed)
Meeting Info:
Session Info:

Acute Treatment: Systemic Thrombolysis and Cerebroprotection Posters II

Thursday, 02/06/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
Acute Stroke Treatment Metrics and Outcomes in Telestroke vs Non-Telestroke Care within the Paul Coverdell Michigan Stroke-Registry

Stamm Brian, Scott Phillip, Sheth Kevin, Reeves Mathew, Levine Deborah, Whitney Rachael, Royan Regina, Ibrahim Ghada, Nickles Adrienne, Ferber Rebecca, Hsu Wan-ling, Hayward Rodney, Mcdermott Mollie

Automated Identification of Stroke Thrombolysis Contraindications from Synthetic Clinical Notes

Chen Bing Yu, Hussain Muhammad, Gonzalez Marco, Antaki Fares, Delora Adam, Aube Eric, Albahra Samer, Robertson Scott, Uchino Ken, Russman Andrew

More abstracts from these authors:
High Mechanical Thrombectomy Procedural Volume is Not a Reliable Predictor of
Improved Thrombectomy Outcomes in Patients with Acute Ischemic Stroke in the
United States

Qureshi Adnan, Spiotta Alejandro, Zaidi Syed, Kwok Chun Shing, Maqsood Hamza, Bhatti Ibrahim, Ford Daniel, Gomez Camilo, Hanley Daniel, Hassan Ameer, Nguyen Thanh, Siddiq Farhan

Relationship Between Timing of Carotid Artery Stent Placement and One Month Rate of Stroke and or Death: Analysis of The National Vascular Quality Initiative

Suri Fareed, Khan Mohammed Sulaiman, Tolba Hatem, Gomez Camilo, Qureshi Adnan

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)